High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$289K
$289,295
Total Sells (Filtered)
$16.3M
$16,327,396
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LENZ
M
LENZ Therapeutics, Inc.
Olsson Shawn
• Officer • Chief Commercial Officer
Other
2025-11-17
$20,800
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Other
|
2025-11-17 | $20,800 | M | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Olsson Shawn
• Officer • Chief Commercial Officer
10b5-1 SellΔOwn -28.6%
2025-11-17
$108,411
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
Officer • Chief Commercial Officer
10b5-1 SellΔOwn -28.6%
|
2025-11-17 | $108,411 | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Olsson Shawn
• Officer • Chief Commercial Officer
10b5-1 SellΔOwn -55.0%
2025-11-17
$152,612
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
Officer • Chief Commercial Officer
10b5-1 SellΔOwn -55.0%
|
2025-11-17 | $152,612 | S | Form 4 |
|
LENZ
P
LENZ Therapeutics, Inc.
Chevallard Daniel R.
• CFO
Discretionary BuyΔOwn +67.9%
2025-11-07
$49,563
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
CFO
Discretionary BuyΔOwn +67.9%
|
2025-11-07 | $49,563 | P | Form 4 |
| LENZ |
LENZ Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-11-07 | $239,278 | P | Form 4 |
| LENZ |
LENZ Therapeutics, Inc.
|
CFO
Discretionary Buy
|
2025-11-07 | $454 | P | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$2,668,484Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $2,668,484Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$2,254,174Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $2,254,174Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$1,560,428Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $1,560,428Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$3,854,827Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $3,854,827Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$8,321
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $8,321 | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$5,783
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $5,783 | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$2,057,871Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $2,057,871Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$1,013,568Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $1,013,568Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$1,759,156Large
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $1,759,156Large | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$866,441
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $866,441 | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$11,604
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $11,604 | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$5,716
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $5,716 | S | Form 4 |